2m 2m 2m 2m 2m 2m 2m
Earth Science Te (ETST)
OTC
$0.15-$0.010 (-6.07%)
Price as of Jun 24, 2026- $46.0MMarket Cap
- 0.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Earth Science Te (ETST)
$0.15-$0.010 (-6.07%)
Annual
Quarterly
03/31/2026 | 03/31/2025 | 03/31/2024 | 03/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 34.7M +6.07% | 32.8M +48,832.96% | -67,207 -238.47% | 48,537 +243.67% | |
Cost of Revenue | 10.2M +15.76% | 8.8M +113.75% | 4.1M +15,480.08% | 26,477 +16.95% | |
Gross Profit | 25.5M +4.89% | 24.3M +210.41% | 7.8M +35,387.29% | 22,060 +359.04% | |
Sales and Marketing Expense | 2.8M +239.43% | 836,860 +3,209.97% | 25,283 +213.14% | 8,074 +120.90% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Depreciation and Amortization Expense | 284,396 +87.53% | 151,654 +1.27% | 149,749 +756.15% | 17,491 +622.47% | |
Total Operating Expenses | 22.2M +6.37% | 20.9M +200.63% | 6.9M +623.46% | 958,743 +339.41% | |
Operating Profit | 3.1M -8.34% | 3.4M +277.70% | 892,349 +195.27% | -936,683 +313.17% | |
Interest Income | N/A N/A | 17 N/A | N/A N/A | 618,711 -82.25% | |
Interest Expense | -14,000 -33.93% | -21,189 -68.47% | -67,207 +41.69% | -47,433 +335.13% | |
Interest Income and Expense and Net | -14,000 -33.87% | -21,172 -68.50% | -67,207 -111.76% | 571,278 -83.56% | |
Total Nonoperating Income and Expense | 67,194 +417.12% | -21,189 -68.47% | -67,207 -111.76% | 571,278 -83.20% | |
Income before Taxes | 3.1M -8.34% | 3.4M +308.46% | 825,142 +325.82% | -365,405 -111.52% | |
Income Taxes | -511,676 -538.17% | 116,776 +798.07% | 13,003 N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 3.6M N/A | N/A N/A | 812,139 +322.26% | -365,405 -111.52% | |
Net Income from Continuing Operations Applicable to Common | 3.1M -8.34% | 3.4M +308.46% | 825,142 +325.82% | -365,405 -111.52% | |
Basic EPS and Net Income | 0.01 +9.09% | 0.01 +266.67% | 0.003 +200.00% | -0.003 -105.00% | |
Diluted EPS and Net Income | 0.01 +9.09% | 0.01 +266.67% | 0.003 +200.00% | -0.003 -105.00% | |
Basic Weighted Average Shares | 293.1M -3.44% | 303.5M -1.99% | 309.7M +112.31% | 145.9M N/A | |
Diluted Weighted Average Shares | 293.1M -3.44% | 303.5M -1.99% | 309.7M +112.31% | 145.9M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 796,797 -45.91% | 1.5M +111.15% | 697,721 +1,851.34% | 35,756 +32.71% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 796,797 -45.91% | 1.5M +111.15% | 697,721 +1,851.34% | 35,756 +32.71% | |
Total Current Assets | 3.7M +19.63% | 3.1M +147.21% | 1.3M +2,634.34% | 46,016 +70.80% | |
Accumulated Depreciation | 312,196 +256.87% | 87,482 +112.08% | 41,250 +500.52% | 6,869 N/A | |
Property and Plant and Equipment and Net | 1.5M +9.67% | 1.4M +922.60% | 135,352 -5.49% | 143,213 +8,265.25% | |
Total Long-Term Assets | 1.5M +9.67% | 1.4M +922.60% | 135,352 -5.49% | 143,213 +186.43% | |
Total Assets | 9.0M +26.92% | 7.1M +82.07% | 3.9M +42.28% | 2.7M +3,445.49% | |
Income Taxes Payable | 196,446 +122.16% | 88,427 N/A | N/A N/A | 67,863 N/A | |
Total Short-Term Debt | N/A N/A | 210,080 +586.72% | 30,592 -94.94% | 604,767 +10.50% | |
Total Current Liabilities | 1.9M -38.70% | 3.1M +111.66% | 1.5M +13.71% | 1.3M -30.55% | |
Total Long-Term Debt | N/A N/A | 31,427 -96.90% | 1.0M +395.86% | 204,408 -55.05% | |
Total Long-Term Liabilities | 96,206 +38.82% | 69,305 +14.44% | 60,559 -37.40% | 96,743 N/A | |
Total Liabilities | 1.9M -40.02% | 3.2M +97.03% | 1.6M +1.47% | 1.6M -14.55% | |
Retained Earnings | -24.1M -13.09% | -27.7M -6.46% | -29.7M -2.67% | -30.5M +1.14% | |
Total Stockholders Equity | 7.0M +82.04% | 3.9M +71.21% | 2.2M +100.91% | 1.1M +162.01% | |
Total Shares Outstanding | 291.3M -1.01% | 294.3M -5.06% | 310.0M +9.68% | 282.6M +424.79% | |
Cash Flow | |||||
Cash from Operating Activities | 1.9M -55.61% | 4.4M +262.48% | 1.2M +219.06% | -1.0M +502.67% | |
Capital Expenditures | 756,619 N/A | N/A N/A | 26,520 N/A | N/A N/A | |
Cash from Investing Activities | -1.9M +1.22% | -1.9M +6,994.08% | -26,520 N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -712,917 -58.44% | -1.7M +231.26% | -517,886 -150.94% | 1.0M +487.02% | |
Financials Ratio | |||||
Gross Margin | 70.62% -3.37% | 73.08% -98.83% | 6,237.96% +13,624.92% | 45.45% +175.37% | |
Operating Margin | 8.89% -13.58% | 10.29% +100.78% | -1,327.76% -31.20% | -1,929.83% +20.22% | |
Return on Assets | 45.28% N/A | N/A N/A | 24.58% +194.32% | -26.05% -100.58% | |
Return on Equity | 66.86% N/A | N/A N/A | 48.21% -54.75% | 106.55% +214.71% | |
Revenue Growth | 6.07% -99.99% | 48,832.96% +20,578.00% | -238.47% -197.86% | 243.67% +370.82% | |
Current Ratio | 1.93 +95.17% | 0.99 +16.80% | 0.85 +2,304.55% | 0.04 +146.15% | |
Cash Ratio | 0.41 -11.75% | 0.47 -0.26% | 0.47 +1,613.14% | 0.03 +91.61% | |
Debt-to-Equity Ratio | N/A N/A | 0.06 -86.49% | 0.46 -35.78% | 0.72 +230.23% | |
Debt-to-Assets Ratio | N/A N/A | 0.03 -87.29% | 0.27 -9.31% | 0.30 -97.72% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow